References
- Czyzyk A, Meczekalski B. Cardiovascular and metabolic problems in Turner’s syndrome patients. Arch Perinat Med 2012;18:47–52
- Lacka K. Turner's syndrome – correlation between karyotype and phenotype. Endokrynol Pol 2005;56:986–93
- Akbas BE, Mutluhan H, Savasoglu K. Turner syndrome and 45,X/47,XXX mosaicysm. Genet Counsel 2009;20:141–6
- Sybert VP. Phenotypic effects of mosaicism for 47, XXX cell line in Turner syndrome. J Med Genet 2002;39:217–21
- Tauchmanova L, Rossi R, Pulcarno M. Turner’s syndrome mosaicism 45X/47,XXX: an interesting natural history. J Endocrinol Invest 2001;24:811–15
- Blair J, Tolmie J, Hollman AS. Phenotype, ovarian function and growth in patents with 45,X/47,XXX Turner mosaicism: implications for prenatal counselling and estrogen therapy at puberty. J Pediartr 2001;139:724–8
- Butnariu L, Rusu C, Caba L. Genotype- phenotype correlation in trisomy X: a retrospective study of a selected group of 36 patients and review of literature. Rev Med Chir Soc Med Nat Iasi 2013;117:714–21
- Li CC, Chodirker BN, Dawson AJ. Severe hemihypotrophy in a female infant with mosaic Turner syndrome: a variant of Russell-Silver syndrome? Clin Dysmorphol 2004;13:95–8
- Stochholm K, Juul S, Gravholt CH. Mortality and incidence in women with 47,XXX and variants. Am J Med Genet A. 2010;152A:367–72
- Meczekalski B, Podfigurna-Stopa A. Genetics of premature ovarian failure. Minerva Endocrinol 2010;35:195–209